These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 15950182)

  • 1. Nucleophosmin/B23-binding peptide inhibits tumor growth and up-regulates transcriptional activity of p53.
    Chan HJ; Weng JJ; Yung BY
    Biochem Biophys Res Commun; 2005 Jul; 333(2):396-403. PubMed ID: 15950182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.
    Yeh CW; Huang SS; Lee RP; Yung BY
    Mol Pharmacol; 2006 Oct; 70(4):1443-53. PubMed ID: 16857742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB.
    Lin CY; Liang YC; Yung BY
    Cell Signal; 2006 Nov; 18(11):2041-8. PubMed ID: 16725311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleophosmin/B23 regulates PCNA promoter through YY1.
    Weng JJ; Yung BY
    Biochem Biophys Res Commun; 2005 Sep; 335(3):826-31. PubMed ID: 16099430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway.
    Zhang G; Chen F; Cao Y; See WA
    Urol Oncol; 2007; 25(3):221-7. PubMed ID: 17483019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples.
    Tsui KH; Juang HH; Lee TH; Chang PL; Chen CL; Yung BY
    Acta Pharmacol Sin; 2008 Mar; 29(3):364-70. PubMed ID: 18298902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of nucleophosmin/B23 in the cellular response to curcumin.
    Weng CH; Yung BY; Weng JJ; Wu MH
    J Nutr Biochem; 2011 Jan; 22(1):46-52. PubMed ID: 20303727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic role of nucleophosmin/B23.
    Yung BY
    Chang Gung Med J; 2007; 30(4):285-93. PubMed ID: 17939258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells.
    Messner DJ; Romeo C; Boynton A; Rossie S
    J Cell Biochem; 2006 Sep; 99(1):241-55. PubMed ID: 16598789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma.
    Liu H; Schwartz MJ; Hwang DH; Scherr DS
    BJU Int; 2008 Apr; 101(7):894-901. PubMed ID: 18241249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
    Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
    Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
    Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
    Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW
    Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells.
    Qi W; Shakalya K; Stejskal A; Goldman A; Beeck S; Cooke L; Mahadevan D
    Oncogene; 2008 Jul; 27(30):4210-20. PubMed ID: 18345031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
    Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
    Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.
    Wang X; Yuan S; Wang J; Lin P; Liu G; Lu Y; Zhang J; Wang W; Wei Y
    Toxicol Appl Pharmacol; 2006 Sep; 215(2):168-78. PubMed ID: 16563451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of the aqueous extract of Magnolia officinalis on the responses of human urinary bladder cancer 5637 cells in vitro and mouse urinary bladder tumors induced by N-Butyl-N-(4-hydroxybutyl) nitrosamine in vivo.
    Lee SJ; Cho YH; Park K; Kim EJ; Kang BS; Jung KH; Kim CH; Kim WJ; Moon SK
    Phytother Res; 2009 Jan; 23(1):20-7. PubMed ID: 19048611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc.
    Puca R; Nardinocchi L; Bossi G; Sacchi A; Rechavi G; Givol D; D'Orazi G
    Exp Cell Res; 2009 Jan; 315(1):67-75. PubMed ID: 18996371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.